The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model

The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model

Andrew van Herick,1 C Andy Schuetz,1 Peter Alperin,1 Michael Bullano,2 Sanjeev Balu,2 Sanjay Gandhi21Archimedes, Inc, San Francisco, CA, USA; 2AstraZeneca Pharmaceuticals LP, Wilmington, DE, USAPurpose: Many patients treated for dyslipidemia do not achieve recommended cholesterol goals despite the w...

Full description

Bibliographic Details
Main Authors: van Herick A, Schuetz CA, Alperin P, Bullano MF, Balu S, Gandhi S
Format: Article
Language:English
Published: Dove Medical Press 2012-11-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/the-impact-of-initial-statin-treatment-decisions-on-cardiovascular-out-a11496

Internet

http://www.dovepress.com/the-impact-of-initial-statin-treatment-decisions-on-cardiovascular-out-a11496

Similar Items